# Infants/young children with COVID-19
Pediatric COVID-19 project

# Cohort details 
26 SARS-Cov-2 infected infants (10 asymptomatic, 11 mild and 5 severe patients)
14 healthy matched controls
Age = less than 12 months


# Study design for scRNAseq
scRNA-seq profiling of PBMC from 26 SARS-Cov-2 infected infants/young children (10 asymptomatic, 11 mild and 5 severe patients), as well as 14 healthy matched controls
Antibody titers (anti-SARS and IFN)

# scRNAseq method  
10X Genomics V3 chemistry


# Other measurments 
1- Serum analyte quantitation using Olink (92 Analytes) and ELISA kits (Biolegend) focused on inflammatory and interferon pathways
2- Antibody titers (anti-SARS-CoV-2: Spike, S2 and RBD and anti-IFN)
